Albendazole 400 mg Oral Tablet

DRUG3 trials

Sponsors

Jennifer Keiser

Conditions

AscariasisHookworm InfectionsTrichuriasis

Phase 2

Efficacy, Safety and Acceptability of Ivermectin ODT in PSAC

CompletedNCT06184399

Jennifer KeiserAscariasis, Hookworm Infections, Trichuriasis

Start: 2024-06-05End: 2024-08-09Updated: 2025-09-22

Phase 3

Efficacy and Safety of MOX/ALB Co-administration

CompletedNCT04726969

Jennifer KeiserAscariasis, Hookworm Infections, Trichuriasis

Start: 2021-06-15End: 2021-09-09Updated: 2024-01-24

Efficacy and Safety of Moxidectin-Albendazole Co-administration in SAC

CompletedNCT06188715

Jennifer KeiserAscariasis, Hookworm Infections, Trichuriasis

Start: 2024-05-14End: 2024-08-05Updated: 2025-09-19

Related Papers

Efficacy and safety of ascending doses of orodispersible ivermectin co-administered with albendazole for Trichuris trichiura infections in preschool-aged children in Tanzania: a single-blind, randomised, controlled, dose-ranging, phase 2 trial.

2025-09-17

Efficacy and safety of moxidectin-albendazole combination therapy for Trichuris trichiura infections in school-aged children: a double-blind, randomised, controlled, superiority trial.

2025-07-141 citations

Efficacy and Safety of Moxidectin-Albendazole and Ivermectin-Albendazole Combination Therapy Compared to Albendazole Monotherapy in Adolescents and Adults Infected with <i>Trichuris trichiura</i>: A Randomized, Controlled Superiority Trial

Clinical Infectious Diseases2023-06-2423 citations